HEALIUS LIMITED (HLS)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

HLS - HEALIUS LIMITED
FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 4.75
Index: ASX200 | ASX300 | ALL-ORDS
Healius, formerly Primary Health Care, is an Australian provider of Pathology, Diagnostic and Day Hospital services. It has been listed since 1998.
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$1.50
30 Nov |
0.000 OPEN $1.53 |
0.000 HIGH $1.55 |
3,266,889 LOW $1.41 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
ACL . AHX . ALC . BMT . CAJ . DOC . EBO . HLA . M7T . MDR . MPL . MVF . NHF . PSQ . RHC . SHL . SLA . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | - 60.9 | 3.4 | xxx |
DPS (cps) | xxx | 0.0 | 0.0 | xxx |
EPS Growth | xxx | N/A | N/A | xxx |
DPS Growth | xxx | N/A | N/A | xxx |
PE Ratio | xxx | N/A | 46.2 | xxx |
Dividend Yield | xxx | N/A | 0.0% | xxx |
Div Pay Ratio(%) | xxx | N/A | 0.0% | xxx |
Last ex-div: 07/09 - ex-div 6c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | -60.9 |
DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 1,706.9 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 244.8 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 306.4 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -22.26 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -22.17 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -11.72 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | -9.76 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | -22.17 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 2.72 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 209.4 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 263 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 1,503 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 1,766 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 1,898 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 115 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 1.20 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 76.1 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 4.46 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 1,365 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 247 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 7 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development

Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
HLS STOCK CHART

FNArena News on HLS
1 |
ESG Focus: The Little Big Things – 30-11-2023Nov 30 2023 - ESG Focus |
2 |
Australian Broker Call *Extra* Edition – Nov 29, 2023Nov 29 2023 - Daily Market Reports |
3 |
Rudi’s View: All-Weather Portfolio In 2023Nov 29 2023 - Rudi's View |
4 |
Australian Broker Call *Extra* Edition – Nov 28, 2023Nov 28 2023 - Daily Market Reports |
5 |
Weekly Ratings, Targets, Forecast Changes – 24-11-23Nov 27 2023 - Weekly Reports |
Latest Healthcare services News
1 |
Treasure Chest: Ramsay Health CareOct 26 2023 - Treasure Chest |
2 |
Timing Seems Right For Alcidion GroupJun 21 2023 - Small Caps |
3 |
No Enthusiasm To Combine ACL & HealiusMar 21 2023 - Australia |
4 |
Dr Boreham’s Crucible: AlcidionDec 13 2022 - Small Caps |
5 |
No Straight Covid-Relief For Ramsay Health CareNov 15 2022 - Australia |
6 |
Dr Boreham’s Crucible: Mach7 TechnologiesNov 14 2022 - Small Caps |
7 |
Negative Industry Trends Impact Australian Clinical LabsAug 12 2022 - Small Caps |
8 |
Healius Offers Digital Carrot, Base Remains SoftMay 25 2022 - Australia |
9 |
Ramsay Stakes Future on Mental HealthDec 20 2021 - Australia |
10 |
Ramsay Health Care: Finally A Break-OutNov 09 2021 - Technicals |